KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Twist Bioscience (TWST) Net Margin (2017 - 2025)

Twist Bioscience (TWST) has disclosed Net Margin for 6 consecutive years, with 4631300.0% as the latest value for Q3 2023.

  • On a quarterly basis, Net Margin rose 463138922.0% to 4631300.0% in Q3 2023 year-over-year; TTM through Sep 2023 was 114.88%, a 785.0% decrease, with the full-year FY2024 number at 719882.76%, down 337343724.0% from a year prior.
  • Net Margin was 4631300.0% for Q3 2023 at Twist Bioscience, up from 90.01% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 4631300.0% in Q3 2023 to a low of 324.16% in Q4 2019.
  • A 5-year average of 243623.53% and a median of 114.33% in 2021 define the central range for Net Margin.
  • Peak YoY movement for Net Margin: tumbled -12716bps in 2019, then soared 463138922bps in 2023.
  • Twist Bioscience's Net Margin stood at 324.16% in 2019, then soared by 64bps to 116.83% in 2020, then increased by 7bps to 108.44% in 2021, then increased by 29bps to 77.1% in 2022, then soared by 6006594bps to 4631300.0% in 2023.
  • Per Business Quant, the three most recent readings for TWST's Net Margin are 4631300.0% (Q3 2023), 90.01% (Q2 2023), and 98.3% (Q1 2023).